TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2021

Phase 1 Human Immunodeficiency Virus (HIV) Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Subtype C DNA and MF59-Adjuvanted Subtype C Envelope Protein.

Mina C Hosseinipour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.